Polyphenol diet and exercise as neuroprotective factors in a Drosophila model of Alzheimer's disease

Abstract

Background: Healthy non-pharmacological lifestyle factors, such as regular physical exercise and dietary supplementation, have been shown to significantly improve cognitive outcomes over time compared to a more sedentary lifestyle and poor diet. Furthermore, exercise may serve as a potential protective factor in attenuating the effects associated with cognitive decline that are characteristic of neurodegenerative disorders, such as Alzheimer's disease (AD). Evidence indicates that certain dietary interventions can also attenuate the effects of neurodegeneration and positively impact longevity. Supplementation with polyphenols such as ellagic acid (EA), which is abundant in pomegranate juice, may help provide neuroprotective and longevity benefits.

Methods: This study examined the potential protective potential of EA and exercise and provides insight into the combined use of a polyphenol-rich diet and exercise to enhance behavioral outcomes and lifespan in a transgenic Drosophila melanogaster (fruit fly) model of AD with the Aβ₄₂ gene.

Results: Fruit flies subjected to a 120-minute exercise regimen performed better on a climbing assay than flies that did not exercise. Conversely, flies that exercised for 30 min passed marginally more trials on a learning and memory assay using an aversive stimulus than flies that did not exercise, whereas both groups performed better than flies subjected to the more intense exercise condition.

Conclusion: These results suggest a hormetic effect of exercise regarding memory performance. Finally, flies fed a low dose of dietary EA (0.24 mg/mL) lived significantly longer than flies fed the control diet or higher concentrations of EA, again suggesting a hormetic effect of EA on longevity.

Keywords

animal models / human disease genetics / neuroinflammation / neuroscience

References

[1] Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022; 23(3):1851.

[2] Morgan JE, Ricker JH. Textbook of Clinical Neuropsychology. Taylor & Francis; 2017.

[3] Cunningham EL, McGuinness B, Herron B, Passmore AP. Dementia. Ulster Med J. 2015; 84(2): 79-87.

[4] 2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024; 20(5): 3708-3821.

[5] Hou Y, Dan X, Babbar M, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15(10): 565-581.

[6] Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G. Overview of Alzheimer's disease and some therapeutic approaches targeting aβ by using several synthetic and herbal compounds. Oxidative Med Cell Longev. 2016; 2016:7361613.

[7] Pires M, Rego AC. Apoe4 and Alzheimer's disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci. 2024; 24(1):778.

[8] Fortea J, Pegueroles J, Alcolea D, et al. APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nat Med. 2024; 30(5): 1284-1291.

[9] Lanoiselée HM, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017; 14(3):e1002270.

[10] Karch CM, Goate AM. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015; 77(1): 43-51.

[11] Hollands C, Tobin MK, Hsu M, et al. Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition. Mol Neurodegener. 2017; 12(1):64.

[12] Williamson JD, Espeland M, Kritchevsky SB, et al. Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study. J Gerontol A Biol Sci Med Sci. 2009; 64(6): 688-694.

[13] Gomes-Osman J, Cabral DF, Morris TP, et al. Exercise for cognitive brain health in aging: a systematic review for an evaluation of dose. Neurol Clin Pract. 2018; 8(3): 257-265.

[14] Quigley A, MacKay-Lyons M, Eskes G. Effects of exercise on cognitive performance in older adults: a narrative review of the evidence, possible biological mechanisms, and recommendations for exercise prescription. J Aging Res. 2018; 2020:1407896.

[15] Pontifex MB, Hillman CH, Fernhall B, Thompson KM, Valentini TA. The effect of acute aerobic and resistance exercise on working memory. Med Sci Sports Exerc. 2009; 41(4): 927-934.

[16] Hartman RE, Ross DM. Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology. Front Biosci (Elite Ed). 2018; 10(2): 300-333.

[17] Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010; 4(8): 118-126.

[18] Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease. Taiwan J Obstet Gynecol. 2012; 51(4): 554-564.

[19] Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann Indian Acad Neurol. 2008; 11(1): 13-19.

[20] Mirsane S, Mirsane S. Benefits of ellagic acid from grapes and pomegranates against colorectal cancer. Caspian J Intern Med. 2017; 8(3): 226-227.

[21] Hartman RE, Shah A, Fagan AM, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006; 24(3): 506-515.

[22] Calabrese V, Cornelius C, Trovato-Salinaro A, et al. The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des. 2010; 16(7): 877-883.

[23] Calabrese EJ. The emergence of the dose-response concept in biology and medicine. Int J Mol Sci. 2016; 17(12):2034.

[24] Pennisi M, Crupi R, Di Paola R, et al. Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease. J Neurosci Res. 2017; 95: 1360-1372.

[25] Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev. 2009; 2(5): 270-278.

[26] Rudrapal M, Khairnar SJ, Khan J, et al. Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. 2022; 13:806470.

[27] Barré-Sinoussi F, Montagutelli X. Animal models are essential to biological research: issues and perspectives. Future Sci OA. 2015; 1(4): FSO63.

[28] Bolus H, Crocker K, Boekhoff-Falk G, Chtarbanova S. Modeling Neurodegenerative Disorders in  Drosophila melanogaster. Int J Mol Sci. 2020; 21(9):3055.

[29] Ram KR, Chowdhuri DK. Chapter 1 - drosophila: a model for biotechnologist. In: AS Verma, A Singh, eds. Animal Biotechnology. 2nd ed. Academic Press; 2020: 3-19.

[30] Siddique YH, Naz F, Rahul , Varshney H. Comparative study of rivastigmine and galantamine on the transgenic  drosophila model of Alzheimer's disease. Curr Res Pharmacol Drug Discov. 2022; 2022(3):100120.

[31] Elovsson G, Klingstedt T, Brown M, Nilsson KPR, Brorsson A-C. A novel drosophila model of Alzheimer's disease to study aβ proteotoxicity in the digestive tract. Int J Mol Sci. 2024; 25(4):2105.

[32] O'Keefe L, Denton D. UsingDrosophilaModels of Amyloid Toxicity to Study Autophagy in the Pathogenesis of Alzheimer's Disease. Biomed Res Int. 2018; 2018:5195416.

[33] Panchal K, Tiwari AK. Miro, A rho GTPase genetically interacts with Alzheimer's disease-associated genes (tau, Aβ₄₂and appl) in Drosophila melanogaster. Biol Open. 2020; 9(9):bio049569.

[34] Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993; 118(2): 401-415.

[35] Elliott DA, Brand AH. The GAL4 system: a versatile system for the expression of genes. Methods Mol Biol. 2008; 420: 79-95.

[36] Lu M, Williamson N, Mishra A, et al. Structural progression of amyloid-β Arctic mutant aggregation in cells revealed by multiparametric imaging. J Biol Chem. 2019; 294(5): 1478-1487.

[37] Scholes HM, Cryar A, Kerr F, et al. Dynamic changes in the brain protein interaction network correlates with progression of Aβ₄₂ pathology in drosophila. Sci Rep. 2020; 10(1):18517.

[38] Piazza N, Gosangi B, Devilla S, Arking R, Wessells R. Exercise-training in young Drosophila melanogaster reduces age-related decline in mobility and cardiac performance. PLoS One. 2009; 4(6):e5886.

[39] Watanabe LP, Riddle NC. New opportunities: drosophila as a model system for exercise research. J Appl Physiol (1985). 2018; 127(2): 482-490.

[40] Damschroder D, Cobb T, Sujkowski A, Wessells R. Drosophila endurance training and assessment of its effects on systemic adaptations. Bio-Protocol. 2018; 8(19):e3037.

[41] Sujkowski A, Wessells R. Using Drosophila to Understand Biochemical and Behavioral Responses to Exercise. Exerc Sport Sci Rev. 2018; 46(2): 112-120.

[42] Tinkerhess MJ, Ginzberg S, Piazza N, Wessells RJ. Endurance training protocol and longitudinal performance assays for Drosophila melanogaster. J Vis Exp. 2012; 61:e3786.

[43] Ali YO, Escala W, Ruan K, Zhai RG. Assaying locomotor, learning, and memory deficits in drosophila models of neurodegeneration. J Vis Exp. 2011; 49:e2504.

[44] Long DM, Blake MR, Dutta S, et al. Relationships between the circadian system and Alzheimer's disease-like symptoms in drosophila. PLoS One. 2014; 9(8):e106068.

[45] Seugnet L, Suzuki Y, Stidd R, Shaw PJ. Aversive phototaxic suppression: evaluation of a short-term memory assay in Drosophila melanogaster. Genes Brain Behav. 2009; 8(4): 377-389.

[46] Lim C, Ki Y. Aversive phototaxic suppression (APS). 2020 Bio-Protocol. Preprint bio-protocol.org/prep282.

[47] Ki Y, Lim C. Sleep-promoting effects of threonine link amino acid metabolism in  drosophila neuron to GABAergic control of sleep drive. elife. 2019; 8:e40593.

[48] Sujkowski A, Richardson K, Prifti MV, Wessells RJ, Todi SV. Endurance exercise ameliorates phenotypes in drosophila models of spinocerebellar ataxias. elife. 2012; 11:e75389.

[49] Watanabe LP, Riddle NC. Exercise-induced changes in climbing performance. R Soc Open Sci. 2021; 8(11):211275.

[50] Wang X, Zhao Y, Hu Y, et al. Establishment of a  Drosophila AD model. J Biol Methods. 2016; 3(2):e43.

[51] Chakraborty R, Vepuri V, Mhatre SD, et al. Characterization of a drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects. PLoS One. 2011; 6(6):e20799.

[52] Sujkowski A, Ramesh D, Brockmann A, Wessells R. Octopamine drives endurance exercise adaptations in drosophila. Cell Rep. 2017; 21(7): 1809-1823.

[53] Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N. Oxidative stress and inflammation: what polyphenols can do for us? Oxidative Med Cell Longev. 2016; 2016:7432797.

[54] Ding M, Li H, Zheng L. Drosophila exercise, an emerging model bridging the fields of exercise and aging in human. Front Cell Dev Biol. 2022; 10:966531.

[55] Owusu-Ansah E, Perrimon N. Modeling metabolic homeostasis and nutrient sensing in drosophila: implications for aging and metabolic diseases. Dis Model Mech. 2014; 7(3): 343-350.

RIGHTS & PERMISSIONS

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.